Impact of Interleukin-17 Inhibitor Therapy on Arterial Intima-media Thickness among Severe Psoriatic Patients.

Éva Anna PirosÁkos SzabóFanni RenczValentin BrodszkyKlára SzalaiNoémi GalajdaBálint SzilveszterEdit DósaBéla MerkelyPéter Holló

Published in: Life (Basel, Switzerland) (2021)

By reducing the inflammation of the vascular wall, anti-IL-17 therapy may have a beneficial long-term effect on cardiovascular complications of systemic inflammation.